Skip to main content
Erschienen in: Journal of General Internal Medicine 1/2020

08.11.2019 | Original Research

How Clinicians Discuss Medications During Primary Care Encounters Among Older Adults with Cognitive Impairment

verfasst von: Ariel R. Green, MD, MPH, PhD, Jennifer L. Wolff, PhD, Diane M. Echavarria, MS, Malcolm Chapman, BA, Annie Phung, MS, Devon Smith, BA, Cynthia M. Boyd, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

People with cognitive impairment experience high rates of polypharmacy and potentially inappropriate medication use. How clinicians communicate about medications may affect to what extent patients and family companions understand and participate in decisions about medication use.

Objective

To characterize how primary care clinicians discuss medications during encounters with older adults with cognitive impairment and their companions.

Design

Qualitative content analysis of audio-recorded clinical encounters from SAME Page, a randomized controlled trial to examine the effects of a patient-family agenda setting checklist on primary care visit communication among patients with cognitive impairment. Visits occurred between August 2016 and August 2017.

Participants

Patients were 65 or older, had > 1 incorrect answer on a cognitive screener, and attended visits with a relative or unpaid companion. Clinicians were physicians, nurse practitioners, or physician assistants at participating practices.

Approach

The encounters were transcribed verbatim. We used qualitative content analysis to identify major themes.

Key Results

Patients were on average 79.9 years of age. The average MMSE score was 21.6. About half of clinicians reported practicing for 15 or more years (n = 8). We identified three major themes. First, we found numerous instances in which primary care clinicians introduced patients and companions to key principles of optimal prescribing and deprescribing. Second, clinicians used a variety of approaches to foster shared decision-making about medication use. Third, several challenges prevented clinicians from working together with patients and companions to optimize prescribing and deprescribing.

Conclusions

This study offers insight into key language clinicians can use to initiate discussions about optimizing prescribing, as well as barriers they face in doing so. Examples identified in these transcripts should be tested with patients and caregivers to examine how such communications are received and interpreted. Future research should develop and test interventions that seek to overcome obstacles to optimizing prescribing for older adults with cognitive impairment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Alzheimer's Association. 2015 Alzheimer’s disease facts and figures. Alzheimers Dement. 2015;11(3):332-384. Alzheimer's Association. 2015 Alzheimer’s disease facts and figures. Alzheimers Dement. 2015;11(3):332-384.
2.
Zurück zum Zitat Plassman BL, Langa KM, Fisher GG, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008;148(6):427-434.PubMedPubMedCentral Plassman BL, Langa KM, Fisher GG, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008;148(6):427-434.PubMedPubMedCentral
3.
Zurück zum Zitat Alzheimer's Association. 2018 Alzheimer’s disease facts and figures. Alzheimers Dement. 2018;14(3):367-429. Alzheimer's Association. 2018 Alzheimer’s disease facts and figures. Alzheimers Dement. 2018;14(3):367-429.
4.
Zurück zum Zitat Lyketsos CG. Neuropsychiatric Symptoms in Dementia: Overview and Measurement Challenges. J Prev Alzheimers Dis. 2015;2(3):155-156.PubMedPubMedCentral Lyketsos CG. Neuropsychiatric Symptoms in Dementia: Overview and Measurement Challenges. J Prev Alzheimers Dis. 2015;2(3):155-156.PubMedPubMedCentral
5.
Zurück zum Zitat Elmstahl S, Stenberg I, Annerstedt L, Ingvad B. Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: a 2-year follow-up. Int Psychogeriatr. 1998;10(3):239-252.PubMed Elmstahl S, Stenberg I, Annerstedt L, Ingvad B. Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: a 2-year follow-up. Int Psychogeriatr. 1998;10(3):239-252.PubMed
6.
Zurück zum Zitat Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord. 2010;24(1):56-63.PubMedPubMedCentral Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S. Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord. 2010;24(1):56-63.PubMedPubMedCentral
7.
Zurück zum Zitat Johnell K. Inappropriate Drug Use in People with Cognitive Impairment and Dementia: A Systematic Review. Curr Clin Pharmacol. 2015;10(3):178-184.PubMedPubMedCentral Johnell K. Inappropriate Drug Use in People with Cognitive Impairment and Dementia: A Systematic Review. Curr Clin Pharmacol. 2015;10(3):178-184.PubMedPubMedCentral
8.
Zurück zum Zitat Castelino RL, Hilmer SN, Bajorek BV, Nishtala P, Chen TF. Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs Aging. 2010;27(2):135-148.PubMed Castelino RL, Hilmer SN, Bajorek BV, Nishtala P, Chen TF. Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs Aging. 2010;27(2):135-148.PubMed
9.
Zurück zum Zitat Lin PJ, Fillit HM, Cohen JT, Neumann PJ. Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer’s disease and related disorders. Alzheimers Dement. 2013;9(1):30-38.PubMed Lin PJ, Fillit HM, Cohen JT, Neumann PJ. Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer’s disease and related disorders. Alzheimers Dement. 2013;9(1):30-38.PubMed
10.
Zurück zum Zitat Patel A, Parikh R, Howell EH, Hsich E, Landers SH, Gorodeski EZ. Mini-cog performance: novel marker of post discharge risk among patients hospitalized for heart failure. Circ Heart Fail. 2015;8(1):8-16.PubMed Patel A, Parikh R, Howell EH, Hsich E, Landers SH, Gorodeski EZ. Mini-cog performance: novel marker of post discharge risk among patients hospitalized for heart failure. Circ Heart Fail. 2015;8(1):8-16.PubMed
11.
Zurück zum Zitat Carnahan RM, Lund BC, Perry PJ, Chrischilles EA. The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice? J Am Geriatr Soc. 2004;52(12):2082-2087.PubMed Carnahan RM, Lund BC, Perry PJ, Chrischilles EA. The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice? J Am Geriatr Soc. 2004;52(12):2082-2087.PubMed
12.
Zurück zum Zitat Moga DC, Carnahan RM, Lund BC, et al. Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living Centers. J Am Med Dir Assoc. 2013;14(10):749-760.PubMed Moga DC, Carnahan RM, Lund BC, et al. Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living Centers. J Am Med Dir Assoc. 2013;14(10):749-760.PubMed
13.
Zurück zum Zitat Berdot S, Bertrand M, Dartigues JF, et al. Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohort. BMC Geriatr. 2009;9:30.PubMedPubMedCentral Berdot S, Bertrand M, Dartigues JF, et al. Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohort. BMC Geriatr. 2009;9:30.PubMedPubMedCentral
14.
Zurück zum Zitat Kay GG, Abou-Donia MB, Messer WS, Jr., Murphy DG, Tsao JW, Ouslander JG. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc. 2005;53(12):2195-2201.PubMed Kay GG, Abou-Donia MB, Messer WS, Jr., Murphy DG, Tsao JW, Ouslander JG. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc. 2005;53(12):2195-2201.PubMed
15.
Zurück zum Zitat Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225-233.PubMedPubMedCentral Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225-233.PubMedPubMedCentral
16.
Zurück zum Zitat Sunderland T, Esposito G, Molchan SE, et al. Differential cholinergic regulation in Alzheimer’s patients compared to controls following chronic blockade with scopolamine: a SPECT study. Psychopharmacology. 1995;121(2):231-241.PubMed Sunderland T, Esposito G, Molchan SE, et al. Differential cholinergic regulation in Alzheimer’s patients compared to controls following chronic blockade with scopolamine: a SPECT study. Psychopharmacology. 1995;121(2):231-241.PubMed
17.
Zurück zum Zitat Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401-407.PubMedPubMedCentral Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401-407.PubMedPubMedCentral
18.
Zurück zum Zitat Reeve E, Bell JS, Hilmer SN. Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review. Curr Clin Pharmacol. 2015;10(3):168-177.PubMed Reeve E, Bell JS, Hilmer SN. Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review. Curr Clin Pharmacol. 2015;10(3):168-177.PubMed
19.
Zurück zum Zitat Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738-747.PubMedPubMedCentral Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738-747.PubMedPubMedCentral
20.
Zurück zum Zitat Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-834.PubMed Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-834.PubMed
21.
Zurück zum Zitat Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431. Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431.
22.
Zurück zum Zitat Karlawish J. Measuring Decision-Making Capacity in Cognitively Impaired Individuals. Neurosignals. 2008;16(1):91-98.PubMed Karlawish J. Measuring Decision-Making Capacity in Cognitively Impaired Individuals. Neurosignals. 2008;16(1):91-98.PubMed
23.
Zurück zum Zitat Vick JB, Amjad H, Smith KC, et al. “Let him speak”: a descriptive qualitative study of the roles and behaviors of family companions in primary care visits among older adults with cognitive impairment. Int J Geriatr Psychiatry. 2018;33(1):e103-e112.PubMed Vick JB, Amjad H, Smith KC, et al. “Let him speak”: a descriptive qualitative study of the roles and behaviors of family companions in primary care visits among older adults with cognitive impairment. Int J Geriatr Psychiatry. 2018;33(1):e103-e112.PubMed
24.
Zurück zum Zitat Wolff JL, Roter DL, Boyd CM, et al. Patient-Family Agenda Setting for Primary Care Patients with Cognitive Impairment: the SAME Page Trial. J Gen Intern Med. 2018;33(9):1478-1486.PubMedPubMedCentral Wolff JL, Roter DL, Boyd CM, et al. Patient-Family Agenda Setting for Primary Care Patients with Cognitive Impairment: the SAME Page Trial. J Gen Intern Med. 2018;33(9):1478-1486.PubMedPubMedCentral
25.
Zurück zum Zitat Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002;40(9):771-781.PubMed Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002;40(9):771-781.PubMed
26.
Zurück zum Zitat Doing qualitative research. In: Crabtree BF, Miller WL, eds. Newbury Park: Sage Publications; 1992. Doing qualitative research. In: Crabtree BF, Miller WL, eds. Newbury Park: Sage Publications; 1992.
27.
Zurück zum Zitat Boeije H. A Purposeful Approach to the Constant Comparative Method in the Analysis of Qualitative Interviews. Qual Quant. 2002;36(4):391-409. Boeije H. A Purposeful Approach to the Constant Comparative Method in the Analysis of Qualitative Interviews. Qual Quant. 2002;36(4):391-409.
28.
Zurück zum Zitat Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277-1288.PubMed Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277-1288.PubMed
29.
Zurück zum Zitat Braddock CH, 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999;282(24):2313-2320. Braddock CH, 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999;282(24):2313-2320.
30.
Zurück zum Zitat Elwyn G, Edwards A, Britten N. “Doing prescribing”: how doctors can be more effective. BMJ. 2003;327(7419):864-867.PubMedPubMedCentral Elwyn G, Edwards A, Britten N. “Doing prescribing”: how doctors can be more effective. BMJ. 2003;327(7419):864-867.PubMedPubMedCentral
31.
Zurück zum Zitat Mold JW, Hamm RM, McCarthy LH. The law of diminishing returns in clinical medicine: how much risk reduction is enough? J Am Board Fam Med. 2010;23(3):371-375.PubMed Mold JW, Hamm RM, McCarthy LH. The law of diminishing returns in clinical medicine: how much risk reduction is enough? J Am Board Fam Med. 2010;23(3):371-375.PubMed
32.
Zurück zum Zitat Farrell B, Black C, Thompson W, et al. Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline. Can Fam Physician. 2017;63(11):832-843.PubMedPubMedCentral Farrell B, Black C, Thompson W, et al. Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline. Can Fam Physician. 2017;63(11):832-843.PubMedPubMedCentral
33.
Zurück zum Zitat Bjerre LM, Farrell B, Hogel M, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Can Fam Physician. 2018;64(1):17.PubMedPubMedCentral Bjerre LM, Farrell B, Hogel M, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Can Fam Physician. 2018;64(1):17.PubMedPubMedCentral
34.
Zurück zum Zitat Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 2013;30(10):793-807.PubMed Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 2013;30(10):793-807.PubMed
35.
Zurück zum Zitat Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12):e006544.PubMedPubMedCentral Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12):e006544.PubMedPubMedCentral
36.
Zurück zum Zitat Kerns JW, Winter JD, Winter KM, Kerns CC, Etz RS. Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia. Gerontologist. 2018;58(2):e35-e45. Kerns JW, Winter JD, Winter KM, Kerns CC, Etz RS. Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia. Gerontologist. 2018;58(2):e35-e45.
37.
Zurück zum Zitat Reeve E, Low LF, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552-560.PubMedPubMedCentral Reeve E, Low LF, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552-560.PubMedPubMedCentral
38.
Zurück zum Zitat Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of attitudes toward deprescribing in older medicare beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673-1680.PubMedPubMedCentral Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM. Assessment of attitudes toward deprescribing in older medicare beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673-1680.PubMedPubMedCentral
39.
Zurück zum Zitat Bynum JPW, Barre L, Reed C, Passow H. Participation of Very Old Adults in Healthcare Decisions. Med Decis Mak. .2014;34(2):216-230. Bynum JPW, Barre L, Reed C, Passow H. Participation of Very Old Adults in Healthcare Decisions. Med Decis Mak. .2014;34(2):216-230.
40.
Zurück zum Zitat Belcher VN, Fried TR, Agostini JV, Tinetti ME. Views of older adults on patient participation in medication-related decision making. J Gen Intern Med. 2006;21(4):298-303.PubMedPubMedCentral Belcher VN, Fried TR, Agostini JV, Tinetti ME. Views of older adults on patient participation in medication-related decision making. J Gen Intern Med. 2006;21(4):298-303.PubMedPubMedCentral
41.
Zurück zum Zitat Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-1100.PubMed Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093-1100.PubMed
42.
Zurück zum Zitat Lloyd-Jones DM, Braun LT, Ndumele CE, et al. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2019;73(24):3153-3167.PubMed Lloyd-Jones DM, Braun LT, Ndumele CE, et al. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2019;73(24):3153-3167.PubMed
43.
Zurück zum Zitat Stewart TV, Loskutova N, Galliher JM, et al. Practice patterns, beliefs, and perceived barriers to care regarding dementia: a report from the American Academy of Family Physicians (AAFP) national research network. J Am Board Fam Med. 2014;27(2):275-283.PubMed Stewart TV, Loskutova N, Galliher JM, et al. Practice patterns, beliefs, and perceived barriers to care regarding dementia: a report from the American Academy of Family Physicians (AAFP) national research network. J Am Board Fam Med. 2014;27(2):275-283.PubMed
44.
Zurück zum Zitat Frank C, Godwin M, Verma S, et al. What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them at increased risk of interactions and inappropriate medication use? Can Fam Physician. 2001;47:1198-1204.PubMedPubMedCentral Frank C, Godwin M, Verma S, et al. What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them at increased risk of interactions and inappropriate medication use? Can Fam Physician. 2001;47:1198-1204.PubMedPubMedCentral
45.
Zurück zum Zitat Sudore RL, Boscardin J, Feuz MA, McMahan RD, Katen MT, Barnes DE. Effect of the PREPARE Website vs an Easy-to-Read Advance Directive on Advance Care Planning Documentation and Engagement Among Veterans: A Randomized Clinical Trial. JAMA Intern Med. 2017;177(8):1102-1109.PubMedPubMedCentral Sudore RL, Boscardin J, Feuz MA, McMahan RD, Katen MT, Barnes DE. Effect of the PREPARE Website vs an Easy-to-Read Advance Directive on Advance Care Planning Documentation and Engagement Among Veterans: A Randomized Clinical Trial. JAMA Intern Med. 2017;177(8):1102-1109.PubMedPubMedCentral
46.
Zurück zum Zitat Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890-898.PubMed Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890-898.PubMed
47.
Zurück zum Zitat Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial. JAMA. 2018;320(18):1889-1898.PubMedPubMedCentral Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial. JAMA. 2018;320(18):1889-1898.PubMedPubMedCentral
48.
Zurück zum Zitat Thompson W, Reeve E, Moriarty F, et al. Deprescribing: Future directions for research. Res Soc Adm Pharm. 2019;15(6):801-805.PubMed Thompson W, Reeve E, Moriarty F, et al. Deprescribing: Future directions for research. Res Soc Adm Pharm. 2019;15(6):801-805.PubMed
49.
Zurück zum Zitat Callahan CM, Sachs GA, Lamantia MA, Unroe KT, Arling G, Boustani MA. Redesigning systems of care for older adults with Alzheimer's disease. Health Aff (Millwood) 2014;33(4):626-632. Callahan CM, Sachs GA, Lamantia MA, Unroe KT, Arling G, Boustani MA. Redesigning systems of care for older adults with Alzheimer's disease. Health Aff (Millwood) 2014;33(4):626-632.
Metadaten
Titel
How Clinicians Discuss Medications During Primary Care Encounters Among Older Adults with Cognitive Impairment
verfasst von
Ariel R. Green, MD, MPH, PhD
Jennifer L. Wolff, PhD
Diane M. Echavarria, MS
Malcolm Chapman, BA
Annie Phung, MS
Devon Smith, BA
Cynthia M. Boyd, MD, MPH
Publikationsdatum
08.11.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 1/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05424-6

Weitere Artikel der Ausgabe 1/2020

Journal of General Internal Medicine 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.